Dana-Farber Cancer Institute Identifies New Drug Targets in Aggressive Cancers

Science Daily reports that Dana-Farber Cancer Institute researchers have discovered a previously unknown molecular vulnerability in two rare, aggressive and hard-to-treat types of cancers and believe it may be feasible to attack this weakness with targeted new drugs. Follow the link for the rest of the story.

Dana-Farber is a comprehensive cancer treatment and research center in Boston, MA. It is a principal teaching affiliate of Harvard Medical School and a founding member of Dana-Farber/Harvard Cancer Center, a Comprehensive Cancer Center designated by the National Cancer Institute.